Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinopathy of Prematurity | 4 | 2018 | 56 | 1.180 |
Why?
|
| Autonomic Nervous System | 2 | 2018 | 45 | 1.070 |
Why?
|
| Nasolacrimal Duct | 2 | 2018 | 22 | 0.840 |
Why?
|
| Dacryocystorhinostomy | 2 | 2018 | 27 | 0.840 |
Why?
|
| Strabismus | 6 | 2009 | 47 | 0.720 |
Why?
|
| Lacrimal Duct Obstruction | 1 | 2018 | 22 | 0.630 |
Why?
|
| Oculomotor Muscles | 4 | 2009 | 63 | 0.570 |
Why?
|
| Dexamethasone | 1 | 2018 | 274 | 0.560 |
Why?
|
| Preoperative Care | 1 | 2018 | 350 | 0.530 |
Why?
|
| Heart Rate | 1 | 2018 | 584 | 0.510 |
Why?
|
| Esotropia | 1 | 2015 | 11 | 0.500 |
Why?
|
| Accommodation, Ocular | 1 | 2015 | 16 | 0.500 |
Why?
|
| Sympathomimetics | 1 | 2014 | 11 | 0.480 |
Why?
|
| Caffeine | 1 | 2014 | 69 | 0.450 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 188 | 0.450 |
Why?
|
| Patient Compliance | 3 | 2015 | 464 | 0.450 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 124 | 0.440 |
Why?
|
| Anisometropia | 4 | 2005 | 12 | 0.420 |
Why?
|
| Dopamine | 1 | 2014 | 273 | 0.420 |
Why?
|
| Amblyopia | 4 | 2005 | 28 | 0.370 |
Why?
|
| Ophthalmologic Surgical Procedures | 2 | 2009 | 88 | 0.340 |
Why?
|
| Suture Techniques | 2 | 2007 | 199 | 0.300 |
Why?
|
| Photography | 2 | 2009 | 91 | 0.300 |
Why?
|
| Visual Acuity | 8 | 2015 | 803 | 0.290 |
Why?
|
| Sclerostomy | 1 | 2007 | 3 | 0.280 |
Why?
|
| Eye Movements | 2 | 2006 | 70 | 0.280 |
Why?
|
| Needles | 1 | 2007 | 52 | 0.270 |
Why?
|
| Tendons | 1 | 2006 | 38 | 0.270 |
Why?
|
| Exotropia | 1 | 2006 | 14 | 0.270 |
Why?
|
| Sclera | 1 | 2007 | 58 | 0.270 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 2 | 2004 | 98 | 0.270 |
Why?
|
| Ophthalmoplegia | 2 | 2003 | 55 | 0.270 |
Why?
|
| Infant, Low Birth Weight | 2 | 2018 | 164 | 0.260 |
Why?
|
| Infant | 9 | 2021 | 12302 | 0.240 |
Why?
|
| Child, Preschool | 13 | 2018 | 13777 | 0.220 |
Why?
|
| Photorefractive Keratectomy | 4 | 2005 | 80 | 0.220 |
Why?
|
| Intubation | 1 | 2003 | 18 | 0.220 |
Why?
|
| Treatment Failure | 1 | 2004 | 336 | 0.220 |
Why?
|
| Silicone Elastomers | 1 | 2003 | 35 | 0.220 |
Why?
|
| Treatment Refusal | 1 | 2004 | 75 | 0.220 |
Why?
|
| Eye Abnormalities | 1 | 2004 | 105 | 0.210 |
Why?
|
| Cornea | 2 | 2005 | 645 | 0.210 |
Why?
|
| Foreign-Body Migration | 1 | 2003 | 74 | 0.210 |
Why?
|
| Optic Nerve | 1 | 2004 | 117 | 0.210 |
Why?
|
| Hyperopia | 4 | 2015 | 83 | 0.200 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 5013 | 0.190 |
Why?
|
| Retinal Diseases | 1 | 2004 | 170 | 0.190 |
Why?
|
| Depth Perception | 2 | 2015 | 20 | 0.180 |
Why?
|
| Retrospective Studies | 9 | 2018 | 15853 | 0.170 |
Why?
|
| Lacrimal Apparatus | 1 | 2021 | 121 | 0.170 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 254 | 0.150 |
Why?
|
| Glucocorticoids | 3 | 2018 | 379 | 0.150 |
Why?
|
| Aging | 1 | 2004 | 1165 | 0.150 |
Why?
|
| Eyeglasses | 2 | 2015 | 14 | 0.140 |
Why?
|
| Child | 14 | 2021 | 24064 | 0.140 |
Why?
|
| Humans | 26 | 2021 | 122296 | 0.140 |
Why?
|
| Infant, Newborn | 5 | 2018 | 8096 | 0.130 |
Why?
|
| Female | 18 | 2021 | 64883 | 0.130 |
Why?
|
| Risk Factors | 4 | 2018 | 9902 | 0.130 |
Why?
|
| Laser Coagulation | 2 | 2007 | 128 | 0.120 |
Why?
|
| Male | 16 | 2018 | 59522 | 0.120 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2014 | 168 | 0.120 |
Why?
|
| Gestational Age | 3 | 2014 | 1115 | 0.120 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2014 | 311 | 0.110 |
Why?
|
| Vision Tests | 2 | 2004 | 37 | 0.110 |
Why?
|
| Retinal Detachment | 2 | 2005 | 84 | 0.110 |
Why?
|
| Case-Control Studies | 2 | 2018 | 3229 | 0.100 |
Why?
|
| Asphyxia Neonatorum | 1 | 2012 | 15 | 0.100 |
Why?
|
| Mydriatics | 3 | 2009 | 11 | 0.100 |
Why?
|
| Postoperative Complications | 2 | 2018 | 2997 | 0.100 |
Why?
|
| Treatment Outcome | 5 | 2018 | 12045 | 0.090 |
Why?
|
| Hypothermia, Induced | 1 | 2012 | 158 | 0.090 |
Why?
|
| Myopia | 4 | 2005 | 193 | 0.090 |
Why?
|
| Torsion Abnormality | 1 | 2009 | 34 | 0.080 |
Why?
|
| Lasers, Semiconductor | 1 | 2007 | 9 | 0.070 |
Why?
|
| Microscopy, Acoustic | 1 | 2007 | 17 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2012 | 798 | 0.070 |
Why?
|
| Retina | 2 | 2007 | 457 | 0.070 |
Why?
|
| Nose | 1 | 2006 | 92 | 0.060 |
Why?
|
| Prospective Studies | 6 | 2007 | 5963 | 0.060 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2004 | 15 | 0.060 |
Why?
|
| Sensory Deprivation | 1 | 2004 | 11 | 0.060 |
Why?
|
| Atropine | 1 | 2004 | 30 | 0.060 |
Why?
|
| Body Weights and Measures | 1 | 2004 | 41 | 0.060 |
Why?
|
| Retinoscopy | 1 | 2004 | 9 | 0.060 |
Why?
|
| Efficiency, Organizational | 1 | 2004 | 47 | 0.060 |
Why?
|
| Panuveitis | 1 | 2003 | 2 | 0.060 |
Why?
|
| Chorioretinitis | 1 | 2003 | 2 | 0.060 |
Why?
|
| Toxoplasmosis, Ocular | 1 | 2003 | 2 | 0.060 |
Why?
|
| Toxoplasmosis, Congenital | 1 | 2003 | 3 | 0.060 |
Why?
|
| Lasers, Excimer | 4 | 2005 | 98 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2004 | 92 | 0.060 |
Why?
|
| Refractive Errors | 1 | 2004 | 84 | 0.050 |
Why?
|
| Anesthesia, General | 1 | 2003 | 111 | 0.050 |
Why?
|
| Vision Disorders | 1 | 2004 | 212 | 0.050 |
Why?
|
| Astigmatism | 1 | 2004 | 176 | 0.050 |
Why?
|
| Intracranial Hypotension | 1 | 2002 | 10 | 0.050 |
Why?
|
| Trochlear Nerve Diseases | 1 | 2002 | 4 | 0.050 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2002 | 17 | 0.050 |
Why?
|
| Myasthenia Gravis | 1 | 2002 | 71 | 0.050 |
Why?
|
| Epithelium, Corneal | 1 | 2003 | 172 | 0.050 |
Why?
|
| Endoscopy | 1 | 2003 | 282 | 0.050 |
Why?
|
| Blepharoptosis | 1 | 2002 | 66 | 0.050 |
Why?
|
| Edema | 1 | 2021 | 133 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2003 | 253 | 0.040 |
Why?
|
| Wound Healing | 1 | 2003 | 454 | 0.040 |
Why?
|
| Time Factors | 2 | 2006 | 6182 | 0.040 |
Why?
|
| Age Factors | 1 | 2004 | 2777 | 0.040 |
Why?
|
| Tropicamide | 2 | 2009 | 5 | 0.040 |
Why?
|
| Phenylephrine | 2 | 2009 | 37 | 0.040 |
Why?
|
| Parents | 1 | 2004 | 1016 | 0.040 |
Why?
|
| Stents | 1 | 2003 | 864 | 0.030 |
Why?
|
| Pupil | 2 | 2009 | 70 | 0.030 |
Why?
|
| Drug Therapy, Combination | 3 | 2004 | 1147 | 0.030 |
Why?
|
| Corneal Topography | 2 | 2005 | 191 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 1392 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2004 | 2796 | 0.030 |
Why?
|
| Adult | 4 | 2009 | 28733 | 0.020 |
Why?
|
| Apgar Score | 1 | 2012 | 48 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 113 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2005 | 1362 | 0.020 |
Why?
|
| Birth Weight | 1 | 2012 | 334 | 0.020 |
Why?
|
| Iris | 1 | 2009 | 65 | 0.020 |
Why?
|
| Adolescent | 2 | 2004 | 18940 | 0.020 |
Why?
|
| Middle Aged | 2 | 2009 | 25640 | 0.020 |
Why?
|
| Vitreous Hemorrhage | 1 | 2005 | 9 | 0.020 |
Why?
|
| Vitreous Body | 1 | 2005 | 105 | 0.020 |
Why?
|
| Office Management | 1 | 2004 | 5 | 0.010 |
Why?
|
| Practice Management | 1 | 2004 | 6 | 0.010 |
Why?
|
| Cyclopentolate | 1 | 2004 | 3 | 0.010 |
Why?
|
| Community Participation | 1 | 2004 | 43 | 0.010 |
Why?
|
| Sulfadiazine | 1 | 2003 | 1 | 0.010 |
Why?
|
| Pyrimethamine | 1 | 2003 | 2 | 0.010 |
Why?
|
| Toxoplasma | 1 | 2003 | 10 | 0.010 |
Why?
|
| DNA, Protozoan | 1 | 2003 | 28 | 0.010 |
Why?
|
| Safety | 1 | 2004 | 217 | 0.010 |
Why?
|
| Leucovorin | 1 | 2003 | 50 | 0.010 |
Why?
|
| Antiprotozoal Agents | 1 | 2003 | 37 | 0.010 |
Why?
|
| Antibodies, Protozoan | 1 | 2003 | 64 | 0.010 |
Why?
|
| Pyridostigmine Bromide | 1 | 2002 | 13 | 0.010 |
Why?
|
| Thymectomy | 1 | 2002 | 24 | 0.010 |
Why?
|
| Refraction, Ocular | 1 | 2004 | 298 | 0.010 |
Why?
|
| Diplopia | 1 | 2002 | 41 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2003 | 329 | 0.010 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2002 | 90 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 758 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 2010 | 0.010 |
Why?
|
| Caregivers | 1 | 2004 | 561 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2003 | 907 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 1247 | 0.010 |
Why?
|
| Disease Progression | 1 | 2003 | 1991 | 0.010 |
Why?
|
| Aged | 1 | 2009 | 18785 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 3448 | 0.010 |
Why?
|
| Animals | 1 | 2003 | 33721 | 0.000 |
Why?
|